Pinometostat (EPZ5676): Mechanism of Action

Pinometostat (EPZ5676) MOA:Targeting DOT1L/H3K79 Methylation Pathway for MLL-rearranged Leukemia

🎯 check Pinometostat (EPZ5676) product page

Pinometostat (EPZ5676) is a selective DOT1L inhibitor. It affects IFN-Stat1, STING, and WNT signaling pathways by reducing H3K79 methylation and downregulating target genes, effectively inhibiting cancer cell proliferation, stemness, and promoting apoptosis.

Primary Applications and Mechanism of Action